BioCentury
ARTICLE | Financial News

Proteonomix proposes private placement of convertible preferred stock and warrants

March 12, 2012 7:00 AM UTC

Proteonomix Inc. (OTCBB:PROT), Mountainside, N.J. Business: Proteomics, Gene/Cell therapy Date announced: 3/6/12 Type: Private placement of convertible preferred stock and warrants To be raised: $3.8 ...